The study, which is being carried out in partnership with the University of Bristol, will analyse flea samples submitted by vet practices from across the country.
Practices interested in participating can request flea collection packs by contacting their MSD representative, or by sending an email to infobfp@merck.com.
Participating practices will receive support materials, including flea combs and things to display in waiting rooms.
The campaign follows the success of the Big Tick Project launched in 2015, which examined over 6,000 tick samples in the UK contributing to the largest-ever study of ticks on dogs and cats in Britain.
Daniel Guerrero, Product Manager at MSD Animal Health said: "After receiving such groundbreaking results from the Big Tick Project, we wanted to continue to revolutionise the way that common parasites such as ticks and fleas are understood and treated by both pet owners and vets.
"Fleas are the most important parasite for pet owners and the main source of irritation in pets. Despite this, fleas are still seen as a common nuisance, and not often dealt with effectively. By better understanding what diseases fleas are carrying in the UK, we will be able to better explain the impact of fleas and how to eradicate them through professional advice and treatment from their local vet."
The Big Flea Project will be open to flea pack submissions from 1st of April – 1st of June 2018, with findings of the research published in 2019.
To request your flea collection pack and practice materials, contact infobfp@merck.com
For the study the RVC used VetCompass, its pioneering technology which analyses the veterinary records of 10 million animals from 1,000 veterinary practices in the UK and is now the world’s largest research database of anonymised clinical records.
The college says this made the study the largest-ever conducted into osteoarthritis in dogs under veterinary care – covering 455,557 dogs.
The study found that:
Rottweilers are the breed most prone to osteoarthritis, with the Old English Sheepdog and Dogue de Bordeaux also being very prone to the condition.
The large population of Labrador Retrievers in the UK makes them the most commonly treated breed for osteoarthritis in the UK.
2.5% of dogs involved in the study had osteoarthritis (which would equate to a total of around 200,000 dogs in the UK).
Dogs that were above average weight for their breed were nearly 2.3 times more likely to be diagnosed with the condition.
Males dogs were 1.2 times more likely to have osteoarthritis than female dogs.
The RVC says that on average, dogs receive their first diagnosis by the age of 10.5 years. Of the dogs who are diagnosed with osteoarthritis, 75% of cases are recommended to remain on medication as a form of pain relief.
It is hoped that this research will improve diagnosis times, which will enable dogs suffering from osteoarthritis to be treated faster.
Dr Dan O’Neill, RVC Senior Lecturer and co-author said: "Breed predisposition to disease is now recognised as one of the biggest problems facing dogs. Studies of huge populations, such as this one, are giving us vital insights into breed-related health problems in dogs that would have been impossible before VetCompass. This study has enabled us to positively support changes in dog welfare."
Reference
Anderson KL, O'Neill DG, Brodbelt DC, Church DB, Meeson RL, Sargan D, et al.: Prevalence, duration and risk factors for appendicular osteoarthritis in a UK dog population under primary veterinary care. Scientific Reports 2018,8(1):5641.
Photo: Dog hip arthritis. Richard Meeson.
According to the company, a similar percentage of respondents believe that senior cats would benefit clinically if they monitored blood pressure routinely in their senior years, and nearly 85% said that anti-hypertensive medication would increase the quality of life for their patients.
Time constraints were cited as the main barrier to routinely measuring blood pressure, but all of those questioned would be happy for a trained RVN to measure blood pressure in cats.
Ceva highlights studies which show show that hypertension affects one in eight cats over nine years old3, with the risk increasing as cats age or if they have other conditions such as chronic kidney disease (where one in three cats suffer with hypertension) or overactive thyroid disease (where an estimated one in four cats suffer with hypertension)4, 5, 6.
Rosanne Jepson, specialist in small animal internal medicine at the Royal Veterinary College said: "High blood pressure can cause severe damage to key body organs including the eyes, kidneys, heart and brain. Unfortunately, it is a condition that develops insidiously without early warning signs for the cat owner; a cat may seem perfectly fine until either the blood pressure is checked, or serious consequences of hypertension suddenly occur."
With this in mind, Ceva says it will host the first Feline Hypertension Month this May, to raise awareness of hypertension and improve the detection and management of high blood pressure in cats.
The company is also encouraging practices to take part in the 'Mercury Challenge', a study it is launching in the summer which will, it says, be the largest-ever European study into feline hypertension.
For information on feline hypertension, Feline Hypertension Month or the Mercury Challenge, contact your local Ceva Animal Health account manager.
References
The award was one of six announced at an event hosted in the run up to this year's BSAVA Congress in Birmingham by TV presenter and animal lover, Matt Baker, and retired veterinary surgeon, Chris Laurence MBE FRCVS.
The awards recognise the achievements of remarkable people from the farming, veterinary and charity industries, who go beyond the call of duty to better the lives of animals around the world including veterinary and charity professionals, researchers and volunteers.
Speaking at the ceremony, chair of the judging panel, Chris Laurence, said: "The quality of nominations for this year’s awards surpassed any we’ve had before, and the people and organisations nominated are well deserved winners. It is especially pleasing to see people from different organisations coming together in the name of animal welfare to work together and to provide leadership. Not only do the winners deserve our thanks and praise but all those nominated should be really proud of what they do for the welfare of animals that can’t speak for themselves."
Other winners of this year's Ceva Animal Welfare Awards by category, were:
Chris Laurence Vet of the Year Award supported by Your Dog and Your Cat magazinesRichard Saunders, Veterinary Advisor to the Rabbit Welfare Association and Fund (RWAF)
Charity Team of the Year supported by PDSAThe Dog Breeding Reform Group
Charitable Contribution of the Year supported by Blue Cross Helen Whiteside, Canine Research Associate at Guide Dogs
Farm Animal Welfare Award supported by R.A.B.I. and NADISThe University of Nottingham Dairy Herd Health Group
International Cat Care Welfare of the Year AwardMaria Pinto Teixeira from Animals de Rua (AdR) in Portugal
For further information on the Ceva Animal Welfare Awards visit www.cevawelfareawards.com.
The paper was written by FEDIAF’s Scientific Advisory Board, comprised of independent academics from leading European universities, with the aim of informing both the industry and the public.
Based on recent scientific data, the paper explains the different life expectancies of dogs related to their size, and defines when "old age" sets in. It explains how changes in the digestive tract can affect food intake, how food texture may become a crucial factor, and how aging can lead to changes in energy metabolism and alter the nutrient requirements of senior dogs. It also offers practical guidance to pet owners for feeding an older dog.
Dr Thomas Brenten, Chairman of FEDIAF’s Nutrition & Analytical Science Group said: "Age-related changes in cognitive functions, behaviour, skin, digestive tract, cardiovascular system, respiratory tract, degenerative joint and skeletal function, as well as urinary disorders are the most common issues concerning older dogs. Many of these can be addressed via nutrition."
The paper can be downloaded in the new section on science on FEDIAF’s website: https://tinyurl.com/fediaf-senior-dogs.
The Mayor of Loughton, Councillor Philip Abraham, officially opened the Vets4Pets Loughton veterinary surgery inside Pets at Home at the Epping Forest Shopping Park, before enjoying a guided tour of the bright and modern facility.
Cheryl, who stars in the BBC’s children’s TV show The Pet Factor, said: "It’s fantastic to be able to open the doors to Vets4Pets Loughton and reach a landmark number of practices for the group.
"The opening event gave us chance to meet new clients, and welcome them to the practice."
Cheryl qualified in 2009 and is also a joint venture partner at Vets4Pets Chadwell and Newbury Park in Ilford.
Nick, who qualified in 2008, is also joint venture partner at Newbury Park, Romford, Beckton and Dagenham.
Nick said: "I have always been interested in caring for pets and have several dogs and cats at home.
"I love being a veterinary nurse and I’m delighted to have another opportunity from Vets4Pets to open my fifth practice.
"Once again the process to open a practice has been easy and we’ve had brilliant support on all aspects from Vets4Pets.
"I’m now looking forward to welcoming pets and their owners to Vets4Pets Loughton and providing the highest standard of veterinary care to the area’s pets."
The new practice will create five new jobs, with two vets, veterinary nurse, two pet care assistants and a receptionist.
Chief executive of the Pets at Home Vet Group, Andrei Balta, said: "Cheryl and Nick are two great advocates for the veterinary profession and we’re delighted they are part of the group.
"Wherever we have opened, pet owners have responded enthusiastically to our state-of-the-art practices and convenient opening hours.
"The joint venture model we operate across our practices provides the support vets and vet nurses need to run their businesses.
"It allows them to focus on what they really love, looking after the health of animals, while the support team helps with other areas including marketing, HR and business strategy."
For the research, Miele commissioned independent market research firm Sapio to interview 1000 pet owners and 100 UK-based vet practices.
Veterinary practices have good reason to worry about complaints: the research showed that 89% of veterinary clients would be quick to tell others if they were dissatisfied with any aspect of the practice or care received. 63% said they would air their grievances on an online review site and 60% said they'd share their views on social media.
Those figures appear to be borne out by the fact that only 10% of vets said they had not seen any negative comments online about their practice.
Interviews with pet owners also found that the top five factors to affect a practice's reputation were: standard of care, a clean and hygienic environment, good customer service, the cost of treatment and waiting times, in that order.
64% of vets agreed that practice hygiene has become increasingly important with cleanliness of staff uniforms and waiting rooms among the first things that customers notice.
The suitably spruce Sam Bailey (pictured right), Sales & Marketing Director for the Professional division of Miele said: "Vet practices are increasingly coming under the same online scrutiny as hotels and restaurants and are being judged on everything from customer service through to staff appearance and waiting times.
"As our research results show, vets are already concerned about their reputations and it’s not just customer service and care outcomes that matter to pet owners, they also have high expectations when it comes to the practice environment too and are looking at cleanliness, hygiene and staff appearance.
"Through our network of approved partners we are working with more and more vet practices throughout the UK to ensure their on premise laundries not only meet WRAS regulations but also support their standards on hygiene, infection control and cleanliness."
The WellVet Weekend will include a variety of sporting activities, yoga classes, wellbeing workshops and social times, all finished off with a gala dinner. Something for everyone.
Speaking at the gala dinner on the Saturday evening will be Rob Pope. Rob, also known as the 'real-life Forrest Gump' is an emergency vet by night and a marathon runner by day. He's the first person ever to run across the USA four times in one year and he's currently running across the USA for the fifth time. This will be Rob’s first public event following his completion of this epic journey.
Liz Barton, Founder of Vetsnet said: "I love sport and I love this profession, so it's fantastic to be able to organise a weekend dedicated to the physical and mental wellbeing of vets and vet nurses. It promises to be a brilliant weekend, and I’m excited to have Rob Pope join us to share his stories from the road."
Ru Clements, Founding Partner of VetLed said: "We’re excited to create a community which supports veterinary professionals to thrive. The WellVet Weekend is a very special concept with a core mission that we wholeheartedly believe in. We hope we can make a long-lasting positive difference to those who attend the first WellVet Weekend."
For more information and to buy your ticket, visit www.wellvet.co.uk
Jon (pictured right, in blue) has devised the fundraising event as part of his BEVA Presidential year. He has put together three routes in Yorkshire to suit all abilities, over the same roads used by Ron Kitching, the champion 1930s road racer. Each route starts and finishes at York racecourse and will be supported with signage and feed and watering stops along the way.
Participants can choose from a 35 mile largely flat 'trot' which takes in the city of York, a 66 mile slightly hilly 'canter' skirting the Yorkshire Wolds and a 91 mile 'gallop' over the Rosedale Chimney, which, according to Jon has "enough ascent to make Sir Chris Bonnington happy!"
There will also be a short family ride on the afternoon of 2nd June so that children and less practised cyclists can get involved.
To enter visit http://www.wheelsinwheels.com/BEVA_Presidents_challenge_Sportive_UK.php
For further information visit www.beva.org.uk
The procedure was performed in Canada through an international collaboration between partners from Germany, Canada and the UK, who say that this was a case where the placement of the tumour made it impossible to operate without severely impacting the dog’s quality of life. The most suitable treatment was a total excision of the growth and reconstruction with an implant.
The implant was designed with medical CAD tools by German company, Voxelmed, using 3D imaging from the affected area. The dog's veterinary surgeon, Julius Liptak, contributed to the design to ensure it met specifications and allowing him to plan the procedure in advance.
UK company Renishaw then additively manufactured the patient specific implant (PSI) at the Additive Design In Surgical Solutions (ADEISS) Centre in London, Ontario, Canada.
Ed Littlewood, Marketing Manager at Renishaw’s Medical and Dental Products Division said: "Without the advancements in additive manufacturing technology, this dog would not have had such a long and happy future ahead of him.
"Prior to this case, many veterinary surgeons were unaware that the technology was available. Similar procedures are now being planned in Germany and further research is underway to see how animals can benefit from additively manufactured PSIs.
Jan Klasen, veterinary surgeon, 3D designer and CEO of Voxelmed said: "Without AM technology, it would have been almost impossible to reconstruct the dog’s maxilla after tumour removal, because the area was extremely complex in geometry. The implant had to have a similar shape and functionality as the dog’s existing bone structure.
"Using additive manufacturing to maintain the original shape and function of the oral and nasal cavity ensures a high quality of life for the dog, just as a naturally shaped skull and maxilla helps the dog to breathe and eat easily."
To read the full case study, visit http://www.renishaw.com/en/additive-manufacturing-in-veterinary-surgery-saving-a-well-loved-member-of-the-family--42950.
The company says the new method, which was developed with Professor Ian Ramsey at the University of Glasgow, has been introduced following recent studies that showed a lack of correlation between ACTH stimulation test results and the clinical status of dogs treated with Vetoryl 1,2
Craig Sankey, Brand Manager at Dechra Veterinary Products, said: "Vetoryl is a medicine that will normally deliver major clinical benefits to a patient with canine Cushing's syndrome but finding a stable, long-term dosing regimen can be hard if ACTH stimulation tests return varying results.
"Pre-Vetoryl Cortisol monitoring is a reliable alternative to traditional ACTH stimulation tests for several reasons. It predicts clinical signs better, gives more consistent results, is less expensive and is easier to perform.
"Our online guide gives veterinary professionals a detailed insight into how they can integrate PVC into their treatment plans and the benefits it can bring to their patients and practice."
Information about Pre-Vetoryl Cortisol monitoring is now available at www.dechra.co.uk/prevetorylcortisol, together with other resources for patients on Vetoryl.
Dechra also hosts a website for owners whose pets have been prescribed Vetoryl: www.canine-cushings.co.uk.
The RCVS statement, which can be read in full here, highlighted the fact that there is no body of evidence that homeopathy is effective and nor is it based on sound scientific principles. It should therefore be considered as complementary rather than alternative to treatments which are based on sound scientific principles, or for which there is a recognised evidence base.
In fact, the RCVS statement said nothing new. The principle that veterinary surgeons must first prescribe licensed medicines tested for safety and efficacy is enshrined in the Veterinary Medicines Regulations 2013, which say that if there is no veterinary medicine authorised in the United Kingdom for a condition in a particular species the veterinary surgeon responsible for the animal may treat with a veterinary medicine authorised for use in another animal species or for another condition in the same species, or, failing that, either a medicine authorised in the UK for human use, or a veterinary medicine authorised in another member state for use with any animal species in accordance with the Special Import Scheme, or a specially prepared (extemporaneous preparation or special) medicine, or exceptionally a medicine imported from outside the EU.
There are no homeopathic treatments listed by the VMD as 'authorised', just a handful of homeopathic preparations listed as 'registered', something which, as the BAHVS itself points out, means they have not been subjected to the same evaluation as authorised medicines or tested for efficacy.
The BAHVS is fond of using anecdote as evidence of efficacy (see the endorsements at the foot of this page: http://www.bahvs.com/), so one veterinary surgeon has been inviting colleagues to share their experiences of homeopathy causing harm on social media, in order to produce an infographic (pictured above right, click to enlarge) highlighting the very real harm caused when, for example, owners 'vaccinate' against parvo with homeopathic nosodes, only to have a dead litter on their hands.
The draft infographic can be found here.
The consultation, which was held by the College early in 2017, asked for the views of veterinary surgeons and nurses, animal owners, and stakeholders on the use of telemedicine in veterinary clinical practice.
The consultation was designed to help identify potential risks associated with telemedicine, identify areas where it may help address the needs of both clinicians and the public, and support the potential development of new professional standards and guidance.
The online survey of veterinary professionals received 1,230 responses, while the public consultation received 229 responses and the survey of organisations/stakeholders received eight responses.
The headline question asked of veterinary professionals was whether RCVS 'supporting guidance to the Code of Professional Conduct' should be amended to allow remote examination to take the place of physical examination in certain circumstances. 41% said 'Yes', 40% said 'No' and 18% were unsure.
Veterinary professionals and organisations were then asked a series of questions in order to establish how they rated the risk associated with telemedicine according to activity type, practice type, clinical sign or syndrome, mode of technology, and familiarity with client, animal or environment.
Unsurprisingly perhaps, the majority felt that providing just general advice presented a low risk. At the other end of the scale, most felt that the use of telemedicine to diagnose disease or injury would be either 'high risk', or 'not appropriate at all'.
Likewise, the majority said the risks would be low or medium where the client and environment were known and the animal seen before, for the same problem. By contrast, the majority said telemedicine would be either 'high risk' or 'not appropriate at all' when the client, animal and environment were all unknown.
When asked whether the current definition of 'under care' should be extended to allow veterinary surgeons to prescribe veterinary medicines where there has been no physical examination of the animal, 69% said 'No', 16% said 'Yes' and 15% were unsure.
However, when asked whether certain types of veterinary medicines should be able to be prescribed without a physical examination of the animal, the majority of respondents to the professional survey (52%) were in favour.
The results of the consultation were first considered at a special meeting of the Standards Committee in August 2017, where it was noted how the consultation had revealed significant confusion around current supporting guidance to the RCVS Code of Professional Conduct and that, at a minimum, clarification as to what was currently permissible was needed.
The Committee determined a key issue going forward was whether to change the Supporting Guidance to the RCVS Code of Professional Conduct regarding 'under care' to allow veterinary surgeons to prescribe POM-V medicines based on telemedicine alone.
Given the complex nature of the issues and the wide-ranging implications, the Standards Committee presented a range of options for amending RCVS Guidance to RCVS Council at its meeting in November 2017. After discussion, Council asked the Standards Committee to continue their review and to present more detailed proposals to Council regarding the future of telemedicine in clinical veterinary practice.
Anthony Roberts, RCVS Director of Leadership and Innovation, said: "We would like to thank all those who took the time to respond to the consultation – although Council has not yet made any firm decisions, we felt it would be useful to share our research so far.
"The use of telemedicine is growing rapidly in human healthcare and it is only right the RCVS assesses the opportunities it could bring to improve access to veterinary services. It is critical, however, that we understand the issues it presents 'at the coal face' and consider all the available evidence before making any changes to our Guidance. The RCVS should ensure its regulatory framework fosters innovation and maximises the opportunities to improve the quality, efficacy and accessibility of veterinary services, whilst at the same time protecting animal health and welfare."
The Standards Committee will meet again in April 2018 to take further evidence and develop proposals to take the issue forward.
Meanwhile, the full summary is available on the College’s website: www.rcvs.org.uk/telemeds-summary/.
There were two charges against Mr Staton, the first being that he failed to comply with eight requests from the RCVS sent by letter between November 2014 and August 2017 in relation to his continuing professional development (CPD) records.
The second charge was that between 1st January 2012 and 7th November 2017 he failed to have professional indemnity insurance or equivalent arrangements in place.
Mr Staton’s request to adjourn the hearing and agree undertakings was not opposed by the RCVS. The Committee had regard to advice of the Legal Assessor and submissions from both counsel for the RCVS and legal advisor for Mr Staton. In accepting Mr Staton’s request for adjournment and his undertakings no admissions have been made in respect of the charges against him.
In deciding whether to accept the adjournment and undertakings, the Committee was asked to consider a number of factors including Mr Staton’s age and health, his unblemished career of more than 50 years, the fact that he had closed his practice and retired from clinical practice on 31 March 2018 and that he had no intention of practising as a veterinary surgeon again. For those reasons the Committee felt it would be disproportionate to take Mr Staton through a full hearing.
Ian Green, chairing the Committee and speaking on its behalf, said: "In coming to this decision the Committee considered the respondent’s application to adjourn this inquiry in the light of the evidence he adduced. It had regard to the interests of justice, the public interest in ensuring high standards are maintained by veterinary surgeons and the need to ensure the protection of animals and their welfare."
Should Mr Staton seek to apply to rejoin the Register then the proceedings will become active again and a Disciplinary Committee hearing will be scheduled.
As part of the partnership between the two companies, anyone who takes part in one of Improve's CPD courses in 2018 will be entitled to 6 months' half-price pet insurance from Agria.
Online Bitesize CPD modules cover topics including: cardiology, ophthalmology, small animal medicine, feline medicine and exotic animals. Modules are 20, 40 or 60 minutes in length and provide veterinary professionals with interactive experiences which count toward annual CPD requirements in short convenient bursts, earning digital badges and certificates to demonstrate total CPD achieved.
Nick White, Head of Veterinary Channel at Agria, said: "We’re delighted that our partnership with Improve International will give veterinary professionals free, instant access to high-quality and engaging CPD. Not only are the modules available varied and highly relevant, the 'bitesize' nature of the training makes it extremely convenient for busy practice staff to access.
"This is a great incentive for any practices not yet working with Agria to get onboard. As well as benefitting from free CPD, practices will also be working with a specialist lifetime insurer offering 5 weeks free insurance policies and much more for clients and their pets."
For more information, contact your Agria Business Development Manager or visit: www.agriapet.co.uk/bitesize and complete the Contact Us section, using 'FREE CPD' in the subject line of the enquiry box.
Ines, who graduated from the University of Santiago de Compostela in Spain in 2001, has spent the last seven years working at universities in America, Australia and Europe. She undertook her PhD in MR spectroscopy of the brain in dogs at the University of Bern-Zurich in Switzerland. She has a Masters in Radiology from University of Glasgow. She has also worked at the University of Illinois and Sydney University.
Willows clinical director Toby Gemmill said: "Ines is highly qualified and highly regarded, so is a very welcome addition to our talented imaging team. Her experience of working around the world will also be a terrific asset to the practice."
Ines said: "I am very happy and honoured to be joining Willows and to now be part of such a great diagnostic imaging team. "This is a well-known centre of excellence and I’m really looking forward to helping deliver the first class care and treatment that Willows always aims to provide."
For more information, visit www.willows.uk.net.
The charges were:
On 28 September 2015 she was convicted of stealing three packets of Tramadol to the value of £45 from Milton Keynes Veterinary Group.
On 20 April 2017 she was convicted on two counts of issuing a false prescription with the intention of being dispensed Tramadol.
On 15 June 2017 she was convicted of numerous counts of making false prescriptions, as well as stealing £108.47 worth of scratch cards and cigarettes from Premier Queensway Stores.
Between 5 January 2015 and 25 August 2015 she held herself out as a registered veterinary nurse when she was in fact not on the Register, and worked at two separate veterinary practices during that time; and that she was therefore either (i) being dishonest, or (ii) ought to have known that she was not registered.
That on or around 13 April 2016, she made a written representation on an application form for restoration to the Register that she had no criminal convictions, when on 28 September 2015 she had been convicted of burglary and that conviction was not spent; and that she was (i) either dishonest, or (ii) ought to have known that the representation was false.
Ms Wilde admitted charges 1-3, and the Committee were also provided with copies of the convictions. The Committee therefore found charges 1-3 proven.
In considering the fourth charge, they took into account Ms Wilde’s submission that she believed the submission of a cheque would be enough to restore her to the Register. The Committee noted that she had restored herself to the Register in the past, however, and so would have been aware that a cheque alone was not sufficient, and she had also been sent a restoration form following a telephone call with the College on 2 January 2015. The Committee therefore found that Ms Wilde was being dishonest, and determined that charge 4(i) was proven.
In considering the fifth charge, the Committee considered Ms Wilde’s submission that a Probation Officer had told her that her conviction was spent and that she need not declare it. The Committee believed this to be highly unlikely, however, especially as Ms Wilde had provided no evidence from the probation service to support this assertion. The Committee therefore found her to be dishonest, and charge 5(i) to be proven.
The question of whether the facts amounted to serious professional misconduct was, however, solely a matter for the Committee’s judgement. It determined that Ms Wilde’s conduct in relation to charges 1-3 had fallen far short of the standard expected of an RVN and her conduct clearly renders her unfit to practise as an RVN.
Similarly, the Committee found that Ms Wilde’s conduct had fallen far short of the standard expected of an RVN in respect of charges 4-5, and found her conduct clearly amounted to disgraceful conduct in a professional respect.
The Committee then turned to the question of sanction, firstly in respect of charges 1-3. It considered some testimonials that spoke on Ms Wilde’s behalf, but noted that they were all unsigned and none made any reference to the charges against her. The Committee also bore in mind that Ms Wilde had no previous disciplinary history and was apologetic and remorseful, and that no harm had come to animals or humans by her actions.
It also considered, however, that her behaviour had been repeated and sustained, that she had used her knowledge as an RVN to forge prescriptions, and that she had breached the trust of her employers by stealing from them. The Committee therefore decided that removal from the Register was the only appropriate sanction.
When considering sanction in respect of charges 4-5, the Committee took into account that Ms Wilde had difficult personal circumstances and was sincerely apologetic. Using her title of RVN to gain employment when she was not on the Register, however, and breaching the trust of the College by making a false declaration, were considered serious aggravating features. It therefore considered that removal from the Register was again the only appropriate sanction.
Judith Way, who chaired the Committee and spoke on its behalf, said: “Ms Wilde’s criminal behaviour failed to maintain public confidence in the veterinary nursing profession and it failed to declare and uphold proper standards of conduct and behaviour.
“She also knew that she was not registered as an RVN, yet she held herself out as being so and obtained employment in that capacity. In holding herself out in this manner she potentially put her colleagues at risk. She could have compromised the practices that employed her in the capacity of an RVN as their insurance had the potential to be invalidated.
“Ms Wilde was also dishonest with the RCVS when she completed the application for restoration of registered veterinary nurses’ form by stating that she had no convictions. Following this application, Ms Wilde went on to commit the seven further offences (from December 2016 to March 2017) for which she was later convicted in the Northampton and Leicester Magistrates’ Courts. The committee considered that such conduct falls far short of the standards expected of an RVN.”
Ms Wilde may appeal the Committee’s decision within 28 days of being informed of it. If no appeal is received, the Committee’s judgment takes effect.
The Australian company, which launched in the UK offering equine specials in March 2017, says that while some human healthcare companies are authorised to supply veterinary specials under licence in the UK, it is currently the only company in the UK to have specific veterinary authorisation to manufacture sterile specials.
There are six formulations in Bova’s new small animal range with a further 23 formulations scheduled to be introduced in the first half of 2018. However, Bova says that due to advertising restrictions, only verified veterinary surgeons will be able to see its formulation list.
For more information, contact Bova Sales Manager Emma Jones on tel: 07780443731 or Victoria Dawson on 07780443738 or visit www.bova.co.uk.
The company will also be at BSAVA Congress this week on stand 817, where they will be offering the chance to win an afternoon champagne tea at the Ritz.
The webinars are presented by Dr Rachel Dean BVMS PhD MSc(EBHC) DSAM(fel) SFHEA MRCVS, Clinical Associate Professor in Feline Medicine at the School of Veterinary Medicine and Science, Nottingham and founding Director of the Centre for Evidence-Based Veterinary Medicine (pictured right).
The first webinar kicks off at 8:00pm on Tuesday 17th April, when Rachel will give an introduction to EBVM and reminder of why it is so important in practice.
The second session will follow on 24th April, when Rachel will explain how to find and evaluate evidence, and how you can use it to underpin your clinical decision-making process in practice.
In the final webinar, on Tuesday 1st May, Rachel will use a nutritional case study to demonstrate the real-world clinical application of EBVM concepts.
Lee Danks BVSc BVMS MRCVS, Royal Canin’s Scientific Affairs Manager said: "In this three-part series we hope to summarise EBVM for those unaccustomed to this approach and review how it can help improve our clinical decision-making in practice.
"By taking a step by step approach and delivering 'easily-digestible' lessons over three weeks we hope to answer as many questions vets and nurses have as possible with some highly applicable content from Rachel Dean."
For more information and to register, visit https://vetportal.royalcanin.co.uk/cpd/webinar2018/
The Codes of Professional Conduct for both veterinary surgeons and veterinary nurses stress the need for effective communication with clients and ensuring that informed consent is obtained and documented before treatments or procedures are carried out.
At its January meeting RCVS Standards Committee approved changes to chapter 11 (‘Communication and consent’) of the supporting guidance to the Codes to provide further advice to the professions on matters that should be discussed with clients to ensure informed consent is gained, provide clarification on who can gain consent for a procedure and give some additional guidance on consent forms.
Nick Oldham, Standards and Advisory Manager at the RCVS, said: "We hope that this updated guidance is more accessible, readable and will aid members of the profession in developing a more comprehensive approach to gaining informed consent for treatments and procedures and therefore reduce the risk of miscommunication and misunderstanding which can lead to concerns being raised by clients.
"For example, we have updated our guidance to encourage veterinary surgeons to consider discussing a number of additional factors with a client before obtaining consent. This includes the nature, purpose and benefits of any treatment or procedures, the likely outcomes including potential risks, financial estimates, informing the client when other treatments may have available and checking that the client understands what they are agreeing to rather than assuming the client understands both the potential financial outlay and possible side effects.
"Furthermore, there is now additional guidance for veterinary surgeons on who should be seeking consent. While ordinarily it is expected that the veterinary surgeon undertaking the procedure or providing treatment is responsible for obtaining the client’s consent we know that this is not always practical.
"Therefore we clarify that the responsibility of obtaining consent can be delegated to another veterinary surgeon and, failing that, a registered veterinary nurse or student veterinary nurse could obtain consent provided that they are suitably trained, have sufficient knowledge of the proposed procedure or treatment and understand the risks involved.
"The RCVS Standards and Advice Team is also in the process of producing a series of fictional case studies based on informed consent issues encountered by the College’s Preliminary Investigation Committee which we hope will further help the profession."
The updated supporting guidance can be found in full at www.rcvs.org.uk/consent
The Code of Professional Conduct and its supporting guidance can also be downloaded as an app for smartphones and tablets at www.rcvs.org.uk/codeapp
Members of the profession seeking confidential advice on matters relating to professional conduct can contact the Standards and Advice Team on 020 7202 0789 or advice@rcvs.org.uk
Ziapam is licensed for the short-term control of convulsive disorders and muscle spasms of central and peripheral origin, and for use as part of a sedation or pre-anaesthetic protocol. It is presented in packs containing 6 x 2ml vials.
Simon Boulton MRCVS, marketing manager at TVM said: "As a scheduled intravenous drug it is important that we have batch traceability and the proper monitoring of any side effects of such drugs to make sure current guidelines for use in the SPC are correct. Ziapam is kept at the same concentration of the previously used human generics on the cascade for ease of transition."
Simon added: "Furthermore, we’ve purposefully priced Ziapam such that it is only costs a few pence per dose more than the human generic."
TVM UK has also produced a dosing guide for practices which illustrates the different indications and associated treatment guidelines.
For a copy of the dosing guide or for more information, contact your local Territory Manager, email: help@tvm-uk.com, or call: 01737 781 416.
The new briefing will summarise the latest veterinary innovations, resources and research which are of practical value to those working in practice. In other words, only what you strictly need to know.
Need to Know content will be curated by three practising veterinary surgeons: Liz Barton MRCVS (Small Animal, pictured right), Aoife Byrne MRCVS (Equine), and Rachel Tennant MRCVS (Farm Animal). It replaces InDigestion, VetNurse.co.uk’s previous monthly newsletter which only linked to the most popular content on the site itself. By contrast, Need to Know summarises developments from all sources.
VetNurse.co.uk Editor Arlo Guthrie said: "In these days of information overload, our aim here is to provide busy veterinary nurses with a really succinct summary of anything that really matters, wherever it comes from."
Need to Know is the result of a new partnership between VetNurse.co.uk and Vetsnet, a veterinary wellbeing resource hub set up by Liz to support her colleagues in the profession, and the bulk of any additional advertising revenue generated by the initiative will be ploughed back into Vetsnet.
Arlo added: "Since VetNurse launched back in 2000, content has been entirely curated by me. I like to think that has worked reasonably well. Still, having practising veterinary surgeons involved editorially is a big step forward in making sure our content is always useful and relevant."
Anyone subscribed to receive emails from VetNurse.co.uk on registration will automatically receive Need To Know.
If you have subscribed, but are NOT receiving emails from VetNurse.co.uk, you usually need to log into your email account online and move emails from VetNurse.co.uk from your spam or junk folder into your inbox. Some email providers (notably Hotmail) also allow you to 'whitelist' emails from certain people and organisations. In that case, add 'vetnurse.co.uk' to your whitelist.
If you have unsubscribed from emails from vetnurse.co.uk in the past and now want to resubscribe, email support@vetnurse.co.uk and we’ll remove you from the exclusion list.
Idexx says the new test is proven to identify kidney disease earlier than creatinine1–3, enabling veterinary surgeons to intervene earlier and have a greater impact on patients' health outcomes and quality of life.
The Catalyst SDMA Test was first launched at the company's reference laboratories in 2015, since when Idexx says it has run more than 14 million SDMA patient tests, creating the world's largest database on kidney disease in dogs and cats.
The test was then launched to veterinary practices in the USA and Canada last December, where Idexx says it has now been used by thousands of practices.
Jonathan Ayers, Chairman and Chief Executive Officer of Idexx Laboratories said: "We've seen great enthusiasm for the ability to run SDMA as part of the routine chemistry panel at the point of care, and the North American launch has exceeded our expectations.
"The Idexx SDMA Test represents one of the most significant diagnostic innovations in veterinary medicine in the last 30 years. We're thrilled to bring this essential element of the chemistry panel to our point of care Idexx VetLab suite, allowing veterinarians to utilize the benefits of SDMA immediately during the pet's appointment."
Idexx has also signed an agreement to collaborate with Yale University to explore the test's applications in human health. As a result of the partnership, the SDMA Test has been validated for accuracy in measuring SDMA in human blood samples and the results presented at the 2017 annual meeting of the American Society of Nephrology last November by Yale and IDEXX researchers.
Jonathan added: "SDMA has tremendous potential benefit in human applications as well. And with the Idexx test technology now validated to be able to run on commercial chemistry systems that routinely produce chemistry results in human reference laboratories, we have greater reason to explore the clinical value of this incredible biomarker in human applications. We are excited and grateful for our partnership with Yale University."
Idexx says SDMA is now the subject of more than 30 ongoing research collaborations and has been incorporated into the veterinary profession's International Renal Interest Society (IRIS) kidney disease staging guidelines.
For more information about the IDEXX Catalyst SDMA Test, visit www.idexx.eu/sdma.
With at least 65% of dogs and 39% of cats reported as overweight (1&2), the competition is designed to promote a healthy body shape for cats and dogs, and reward the hard work of pet owners and veterinary nurses for achieving and maintaining a pet’s healthy weight. It is open to patients that are starting out on a weight loss programme, those maintaining a healthy body shape following weight loss and even those who have always been a healthy weight and shape.
Six finalists will be selected from all the entries and invited to attend an awards lunch where the overall winner will be announced. All finalists will receive a £100 shopping voucher and the overall winner will receive a £1000 holiday voucher.
Caroline Burke, Weight Management Specialist at Royal Canin said: "The Healthy Weight Competition is the perfect opportunity for veterinary nurses and owners to tackle this serious disease and prevent it occurring.
"There are many health issues associated with an animal being overweight as well as affecting quality of life, longevity and the welfare of the pet. The Healthy Weight Competition is an ideal opportunity for practices to identify the overweight patients, enrol them on a weight loss programme and enter the competition. It also enables them to reward those cats and dogs who have maintained an ideal body shape and weight over a period of time."
The competition is open until 31st of August 2018.
For more information, visit: www.royalcaninhealthyweight.co.uk or contact your Veterinary Business Manager.
Medivet owns 245 veterinary practices in the UK and its rate of practice acquisition had tripled in the last 12 months.
CEO, Arnold Levy said: "The 25 strong Regional Directors Team is a key strategic line of management and support for all our existing practices, and they are central to the successful integration of our new practices into our hub and spoke model. Even though each of our Regional Directors is an experienced, qualified veterinary surgeon, it is vital that they have time, knowledge and understanding of the Medivet business and operation to confidently support their practices in line with our model, in the right way.
"With the support of the Leadership Team, we will be using these next few months to ensure this newly formed group have all the skills needed to do just that."
Arnold added: "We have taken this deliberate decision to ensure we can maintain the very highest standards of client and patient care. Where our management team and support structures are already in place we will continue with our new acquisitions program, and once our Regional Management operation is fully embedded, we will confidently continue to grow our business in a sustainable, people and patient-first way."